高知特
G
37.26
-0.33
-0.88%
高知特
US · G
#2004 按市值排名
上市于 1970
37.26
-0.33
-0.88%
实时 - 追踪5344个代码 - 心跳于512秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期(2026/Q3)披露持股的机构数量减少了4家。
- 机构持股总比例下降了0.9个百分点。
机构持股
- 机构持股比例
- 108.76% -0.89pp
- 机构数量
- 566 -4
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund79.80%
Hedge Fund12.83%
VC/PE Fund8.68%
Public Company2.02%
Government Pension Fund1.90%
Private Company1.52%
Sovereign Wealth Fund1.16%
Individual/Insider0.92%
Family Office/Trust0.40%
主要股东 截至 2026-06-30
BlackRock
9.43% · 15.84M 股
Nalanda Capital Pte Ltd
8.15% · 13.70M 股
Vanguard Portfolio Management, LLC
6.13% · 10.30M 股
FMR
6.05% · 10.17M 股
AQR Capital Management
5.11% · 8.59M 股
Vanguard Capital Management, LLC
5.06% · 8.51M 股
Dimensional Fund Advisors
3.75% · 6.30M 股
J.P. Morgan Asset Management, Inc.
3.37% · 5.66M 股
Geode Capital Management, LLC
3.17% · 5.33M 股
State Street Global Advisors
3.17% · 5.33M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 26次买入 · 24次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Nallicheri Tyagarajan | Chief Executive Officer | 0.34% |
| Balkrishan Kalra | Senior Vice President OF Financial Services, Consumer & Healthcare | 0.11% |
| Piyush Mehta | Chief Human Resources Officer & Senior VP | 0.09% |
| Michael Weiner | Senior Vice President | 0.06% |
| Riju Vashisht | Chief Growth Officer | 0.04% |
| Anil Nanduru | Senior VP and Global Business Leader of High Tech & Manufacturing, Consumer & Healthcare | 0.04% |
| Laura Conigliaro | Independent Director | 0.04% |
| Mark Verdi | Independent Director | 0.04% |
| James Madden | Independent Chairperson | 0.03% |
| CeCelia Morken | Independent Director | 0.03% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-13 | Balkrishan Kalra | Senior Vice President OF Financial Services, Consumer & Healthcare | Open Market Disposition | -10,000 | $36.79 |
| 2026-09-08 | Sumita Pandit | Senior Vice President | Other Acquisition | +76,713 | -- |
| 2026-08-18 | Anil Nanduru | Senior VP and Global Business Leader of High Tech & Manufacturing, Consumer & Healthcare | Open Market Disposition | -6,191 | $37.03 |
| 2026-08-13 | Sameer Dewan | Senior VP & Global Business Leader | Open Market Disposition | -14,972 | $34.10 |
| 2026-08-12 | Michael Weiner | Senior Vice President | Open Market Disposition | -5,900 | $34.04 |
| 2026-08-11 | Anil Nanduru | Senior VP and Global Business Leader of High Tech & Manufacturing, Consumer & Healthcare | Open Market Disposition | -29,095 | $33.92–33.96 |
| 2026-08-11 | Anil Nanduru | Senior VP and Global Business Leader of High Tech & Manufacturing, Consumer & Healthcare | Intent to Sell (Form 144) | -11,852 | $33.92 |
| 2026-08-10 | Anil Nanduru | Senior VP and Global Business Leader of High Tech & Manufacturing, Consumer & Healthcare | Intent to Sell (Form 144) | -17,243 | $33.96 |
| 2026-04-22 | Mark Verdi | Independent Director | Other Acquisition | +6,521 | -- |
| 2026-04-22 | James Madden | Independent Chairperson | Other Acquisition | +9,999 | -- |
| 2026-04-22 | CeCelia Morken | Independent Director | Other Acquisition | +6,521 | -- |
| 2026-04-22 | Brian Stevens | Independent Director | Other Acquisition | +6,521 | -- |
| 2026-04-22 | John Hinshaw | Director | Other Acquisition | +6,521 | -- |
| 2026-04-22 | Laura Conigliaro | Independent Director | Other Acquisition | +6,521 | -- |
| 2026-04-22 | Nicholas Gangestad | Director | Other Acquisition | +6,521 | -- |
| 2026-04-22 | Carol Lindstrom | Independent Director | Other Acquisition | +6,521 | -- |
| 2026-04-22 | Thimaya Subaiya | Director | Other Acquisition | +6,521 | -- |
| 2026-03-09 | Piyush Mehta | Chief Human Resources Officer & Senior VP | Sale to Issuer | -5,702 | $38.92 |
| 2026-03-09 | Balkrishan Kalra | Senior Vice President OF Financial Services, Consumer & Healthcare | Sale to Issuer | -13,893 | $38.92 |
| 2026-03-09 | Michael Weiner | Senior Vice President | Sale to Issuer | -7,019 | $38.92 |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
高知特 讨论区 0 条评论